Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Starboard has also approached Ian Read, a former Pfizer CEO, and Frank D'Amelio, who served as CFO until 2021, and both ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback